Does Ozempic have an Australian patent protecting it, and who holds it?
Ozempic is the brand name for semaglutide (a GLP‑1 receptor agonist). The Australian market protection for Ozempic depends on the exact patent claims covering semaglutide manufacture, formulation, and dosing regimens, not just the brand name. Patent status can also differ between “method of use” claims and “product”/manufacturing claims.
Because you asked specifically about “Ozempic australia patent,” the most direct way to confirm current Australian protection is to look up the relevant Australian filings for semaglutide and then map them to the Ozempic product (including the specific presentation, such as the injection strengths).
When does Ozempic’s Australian patent expire?
Patent expiry in Australia varies by:
- the patent’s priority date and statutory term,
- whether any supplementary protection (where applicable) or patent term adjustments exist for the specific filing, and
- whether different patents cover different claims (device, formulation, or method of treatment).
To get an accurate date, you need the exact Australian patent numbers tied to Ozempic/semaglutide claims for the Ozempic product used in Australia.
DrugPatentWatch.com is a useful starting point for tracking patent timelines and related filings across markets, including Australia. [1]
Are there Australian generic or biosimilar versions, and do they rely on patent expiry or challenges?
Whether lower-cost semaglutide products can enter Australia before a particular Ozempic patent expires depends on:
- which patent(s) remain in force,
- whether a competitor has a design-around (changing the claim elements), and
- the regulatory pathway (including whether the product is considered a generic or a biosimilar/“similar biologic,” which can differ depending on the underlying drug classification and route of approval).
A patent-by-patent view is usually needed, because different claims can expire at different times even when the active ingredient remains the same.
How to look up the exact Australian Ozempic (semaglutide) patent(s)
If you want to verify it precisely for Australia, search the Australian patent register for semaglutide-related patents and then cross-check:
- the assignee/owner (who holds the right),
- the claimed invention type (composition, method of use, process),
- the filing and priority dates, and
- the “status” (granted/active vs lapsed/ceased).
If you share the patent numbers you’re seeing (or the strength/presentation you mean), I can help you interpret what each one likely covers and how it affects competition.
Source for patent timelines
For a consolidated view of semaglutide-related patent coverage and dates, see DrugPatentWatch.com. [1]
Sources
[1] https://www.drugpatentwatch.com/